Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Postoperative Delirium in Elderly Diabetic Orthopedic Surgery Patients
ChiCTR2600116154Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Guizhou Medical University
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in postoperative delirium (POD), post-operative cognitive decline (POCD) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Affiliated Hospital of Guizhou Medical University. Primary endpoint: Incidence of postoperative delirium during the first 5 postoperative days. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
postoperative delirium (POD)post-operative cognitive decline (POCD)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2600116154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600116154.